Time for a reality check.NAL is close to being insolvent .It must get a rights issue away to either take out the convertible note issue or if that is converted ,provide for more cash until such time that Eyecare is sold .London has been in suspension since Dec because of lack of accounts and the information on Immunology testing is none existent. On last account it was proposed sell off Viresome to get cash.Now I am not saying that the company is behind Fridays move ,only that in my opinion an announcement of a Patent is only that and also I cannot see how Needlefree is linked to Eyecare as one poster reported.The worse thing that could happen to NAL is that day traders get excited because Iam sure that they will dump very quickly.I hold NAL and am in the top ten unfortunately.There is hope for some return of value on events that justify a move up,but last Friday is not one of those and it could I believe, do more harm than good to long term holders.
NAL Price at posting:
1.1¢ Sentiment: Hold Disclosure: Held
